Sarepta Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Sarepta Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Sarepta Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Sarepta Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Sarepta Therapeutics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Sarepta Therapeutics Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Douglas S. Ingram
Chief Executive Officer; Director; President Executive BoardMr. Douglas Ingram has been the Chief Executive Officer, President, and Director of the company since 2017. Prior to this, he served as the Special Advisor on the executive leadership team at Actavis. Mr. Ingram also served as the Chief Executive Officer and President at Chase Pharmaceuticals Corporation since 2015. Previously, he served as the Director at Endo International Plc; Vice Chairman at Nemus Biosciences since 2015; and Director at Pacific Life Insurance Company since 2015.
M. Kathleen Behrens, Ph.D.
Chairwoman Executive BoardDr. M. Kathleen Behrens has been the Chairwoman of the company since 2015. Prior to this, she served as a member of the President’s Council of Advisors on Science and Technology (PCAST). Ms. Behrens also served as the Chairwoman of PCAST’s Subcommittee on Personalized Medicine. Previously, she served as the General Partner and Managing Director of Robertson Stephens & Co.
Ryan H.Wong
Chief Financial Officer; Executive Vice President Senior ManagementMr. Ryan H. Wong has been an Executive Vice President and the Chief Financial Officer of the company since July 2025. Previously, he served as the Senior Vice President of Strategic Finance, Treasury and Investor Relations from March 2025 to July 2025. Earlier, he served as the Vice President of Financial Strategy, Planning & Analysis and Treasury from March 2022 to March 2025. He also served as the Vice President of Financial Strategy Planning & Analysis from July 2021 to March 2022. Prior to this, he served as the Vice President of Finance at GW Pharmaceuticals plc from June 2017 to July 2021.
Ian M. Estepan
Chief Operating Officer; President Senior ManagementMr. Ian Estepan has been the President and Chief Operating Officer of the company since July 2025. Earlier, he served as the Executive Vice President and Chief Financial Officer of the company from 2020 to July 2025. Previously, he served as the Senior Vice President, Chief of Staff and Corporate Affairs from February 2019 to December 2020. Prior to this, he served as the Vice President, Chief of Staff and Corporate Affairs from January 2018 to February 2019. He also served as Executive Director of Corporate Affairs at Sarepta from October 2016 to December 2017. Mr. Estepan has served on the Board of Directors for Cellarity. Mr. Estepan currently serves as Executive Chairman of AbBC Therapies, a private biopharmaceutical company.
Alison Nasisi
Chief People Officer; Executive Vice President Senior ManagementMs. Alison Nasisi has been the Chief People Officer and Executive Vice President of the company since 2021. Prior to this, she served as the Senior Director of the company since 2019. Ms. Nasisi also served as the Director of compensation and work-life at the Broad Institute of MIT and Harvard.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer